Skip to main content

Table 4 CT-scan and pulmonary function test findings

From: Midterm follow-up of healthy young adults with moderate to severe COVID-19: pulmonary and extrapulmonary disease sequelae

Parameters

All Cases

Median (IQR)/% (N)

Non-ICU

Median (IQR)/% (N)

ICU

Median (IQR) /% (N)

P value

Spirometry

    FVC, % predicted

110 (90, 125)

109 (89, 121)

122 (95, 125)

0.295

    < 80%

12.8% (6)

12.5% (4)

13.3% (2)

1.00

    FEV1, % predicted

91 (75, 109)

88.5 (76.0, 101.3)

93.0 (70.0, 120.0)

0.487

    < 80%

29.8% (14)

31.3% (10)

26.7% (4)

1.00

    FEV1/FVC, % predicted

96 (79, 109/)

97 (78, 103)

94 (81, 102)

0.879

    < 70%

11% (5)

13% (4)

7% (1)

0.660

    FEF 25–75, % predicted

70.0 (52.0, 89.0)

69.5 (53.3, 86.3)

77.0 (35.0, 94.0)

0.977

    < 80%

68% (32)

72% (23)

60% (9)

0.416

    Peak expiratory flow, % predicted

75.0 (49.0, 100)

72.5 (47.5, 96.0)

82.0 (51.0, 115.0)

0.356

    < 80%

55% (26)

59% (19)

47% (7)

0.533

Computed tomography (CT)

    Ground-glass opacity

57.8% (26)

50.0% (15)

73.3% (11)

0.135

    Consolidation

2.2% (1)

0.0% (0)

6.7% (1)

0.333

    Fibrosis

33.3% (15)

30.0% (9)

40.0% (6)

0.502

    Subpleural line

11.1% (5)

6.7% (2)

20.0% (3)

0.315

    Reticulation

0.0% (0)

0.0% (0)

0.0% (0)

    Nodules

22.2% (10)

26.7% (8)

13.3% (2)

0.310